Pressure-induced cellular senescence: a mechanism linking venous hypertension to venous ulcers.

INTRODUCTION Slow healing of ulcers in chronic venous insufficiency (CVI) has long been thought secondary to venous hypertension. Dermal fibroblasts isolated from venous ulcers have morphologies and protein production suggestive of premature aging. In this study, we hypothesized that neonatal fibroblasts (NNF) cultured under elevated pressure will demonstrate premature aging and that this effect will be augmented by an inflammatory mediator, transforming growth factor beta (TGF-beta). MATERIALS AND METHODS A unique pressure incubator was used to culture NNF at atmospheric pressure (ATM), ATM + 30 mmHg, ATM + 60 mmHg, and ATM +120 mmHg. Some pressure-exposed NNF were also cultured with TGF- beta (1 ng/ml). Growth rates were determined by flow cytometry. Senescent cells were identified by staining with a marker for cellular senescence, beta-galactosidase (SA-beta-Gal). Light microscopy and digital imaging were used to evaluate cell morphology. Paired linear models and comparison of the slopes were used for statistical analysis of growth. chi2 analysis was used to compare senescence rates. RESULTS NNF cultured at ATM + 60 mmHg and ATM + 120 mmHg showed increased SA-beta-Gal activity (P <0.05), and reduced growth rates (P <0.05) at 11 days. These effects were not seen at ATM + 30 mmHg. NNF grown with TGF-beta did not show augmented SA-beta-Gal staining. CONCLUSIONS Pressure-exposed NNF demonstrated an accelerated aging phenomenon similar to fibroblasts isolated from venous ulcers. This aging effect was directly related to the level of pressure. TGF-beta did not augment the aging effect. This study suggests that pressure elevations result in altered cell function and accelerated aging that may contribute to the slowed healing seen in patients with venous insufficiency.

[1]  J. Menzoian,et al.  Fibroblasts cultured from venous ulcers display cellular characteristics of senescence. , 1998, Journal of vascular surgery.

[2]  J. Menzoian,et al.  Reduced growth of dermal fibroblasts from chronic venous ulcers can be stimulated with growth factors. , 1997, Journal of vascular surgery.

[3]  E. Majewski,et al.  The Social and Economic Burden of Venous Leg Ulcers , 2003, American journal of clinical dermatology.

[4]  J M Edwards,et al.  Long-term hemodynamic and clinical sequelae of lower extremity deep vein thrombosis. , 1986, Journal of vascular surgery.

[5]  B. Lal,et al.  Altered proliferative responses of dermal fibroblasts to TGF-beta1 may contribute to chronic venous stasis ulcer. , 2003, Journal of vascular surgery.

[6]  A. Falabella,et al.  Dermal fibroblasts from venous ulcers are unresponsive to the action of transforming growth factor-beta 1. , 1997, Journal of dermatological science.

[7]  R. Hobson,et al.  Dermal tissue fibrosis in patients with chronic venous insufficiency is associated with increased transforming growth factor-beta1 gene expression and protein production. , 1999, Journal of vascular surgery.

[8]  V. Aboyans,et al.  Epidemiology of venous insufficiency in an occupational population. , 2003, International angiology : a journal of the International Union of Angiology.

[9]  John V. White,et al.  Hemodynamic deterioration in chronic venous disease. , 1992, Journal of vascular surgery.

[10]  A. Nicolaides,et al.  The relation of venous ulceration with ambulatory venous pressure measurements. , 1993, Journal of vascular surgery.

[11]  T. Osler,et al.  Senescence and the healing rates of venous ulcers. , 2001, Journal of vascular surgery.

[12]  A. Nicolaides,et al.  The LONFLIT4-Concorde - Sigvaris Traveno Stockings in Long Flights (EcoTraS) Study , 2003, Angiology.

[13]  T. Osler,et al.  A new in vitro model of venous hypertension: the effect of pressure on dermal fibroblasts. , 2003, Journal of vascular surgery.